The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Naive B Cells Activate & Expand During Lupus Flares

Naive B Cells Activate & Expand During Lupus Flares

June 15, 2015 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

New data shed more light on the contributions of B cells to the pathology of systemic lupus erythematosus (SLE). The data suggest that active SLE is the result of newly generated antibody-secreting cell (ASC) populations that undergo extensive polyclonal expansion. It is not yet clear whether the polyclonal ASCs are generated by the activation of bystander B cells or by the stimulation of multiple lupus autoantigens.

You Might Also Like
  • Patients with Lupus: Plasmacytoid Dendritic Cells Fail to Induce Regulatory B Cells
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
Also By This Author
  • Genetic Analysis Provides Insights into How Human Growth Is Linked to OA

On May 25, Christopher M. Tipton, PhD, an instructor of medicine at Emory University in Atlanta, and colleagues published the results of their deep sequencing, proteomic profiling of autoantibodies online in Nature Immunology.1 They evaluated peripheral blood ASCs from patients with SLE who had minimal immunosuppression and were experiencing a disease flare. Cells from these patients were compared with peripheral blood ASCs from vaccinated healthy control subjects. The investigators sorted and sequenced the rearranged genes, encoding antibody heavy chains from ASCs, naive cells and IgD memory cells. They also measured clonal size, the contribution of large clones and repertoire diversity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers found that naive B cells were highly polyclonal in patients with SLE, as well as in vaccinated controls. In the case of patients with SLE, however, the polyclonal repertoire of the ASCs included abnormally expanded clones selected from a much smaller fraction of cells than those found in vaccinated healthy control subjects. Moreover, a substantial percentage of ASCs from patients with SLE were derived from newly activated naive cells that had persisted in the circulation for several months. SLE flares corresponded with the activation and diversification of these naive B cells (acN). Thus, the selection of SLE autoreactivities involved prolonged recruitment and polyclonal activation of recently activated naive B cells.

“Our study of SLE has delineated the connectivity among B cell subsets during an ongoing autoimmune response. Indeed, a relevant observation was that the two major subsets of circulating ASCs (CD138− ASCs and the more mature CD138+ ASCs) were highly interconnected and represented newly produced proliferative plasmablasts in the process of ongoing maturation,” wrote the authors. They went on to suggest that the population expansion may reflect a recall response to chronic exposure to autoantigens. The study was not designed, however, to identify the autoantigens targeted by the ASC oligoclonal expansion during SLE flares.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Further, the authors explain, “Our results provide new insight into the phenotype, magnitude and downstream consequences of the activation of naive B cells in SLE. Indeed, the previously recognized population expansion of CD21lo activated B cells was ascribed to CD27+ B cells, while other studies did not discriminate among transitional and/or recent immigrant and mature naive B cell subsets, a limitation overcome by incorporation of the analysis of MTG [MitoTracker Green] staining and CD24 expression. Also in contrast with published studies, in our experiments, acN cells were CD23−, a finding consistent with the downregulation of CD23 expression induced by sustained activation of the BCR [B cell receptor], toll-like receptor 9 and interferon-α and interferon-γ, all important stimulatory pathways in SLE.”

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: antibody-secreting cells, autoantibodies, B cells, flare, Lupus, SLE

You Might Also Like:
  • Patients with Lupus: Plasmacytoid Dendritic Cells Fail to Induce Regulatory B Cells
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus
  • Neutrophils & B Cells Create Unique Antibodies in Lupus Patients

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.